Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (51 ops.)
Latest filing published 03 Nov 2022 for Clovis Oncology, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
51
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Paul Edward Gross: trading record in brief
This profile gathers the share dealings of Paul Edward Gross in Clovis Oncology, Inc. Between 5 March 2019 and 2 November 2022, the trades on record add up to 102 filings.
No open-market purchase appears, only 51 sales worth €372k. Outside the open market, there are 51 option exercises. 2022 to date brings no purchases and 12 sales.
The newest entry dates from 3 November 2022: an open-market sale of €2,582, in Clovis Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul Edward Gross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
5,623 sharesCommon StockSEC:0000899243-22-034898:0
5,063 sharesCommon StockSEC:0000899243-22-030420:0
5,624 sharesCommon StockSEC:0000899243-22-027575:0
5,062 sharesCommon StockSEC:0000899243-22-020945:0
5,623 sharesCommon StockSEC:0000899243-22-016293:0
563 sharesCommon StockSEC:0000899243-22-009058:0
5,625 sharesCommon StockSEC:0000899243-22-004569:0
562 sharesCommon StockSEC:0000899243-21-046762:0
5,623 sharesCommon StockSEC:0000899243-21-042701:0
563 sharesCommon StockSEC:0000899243-21-035115:0
5,624 sharesCommon StockSEC:0000899243-21-031438:0
562 sharesCommon StockSEC:0000899243-21-021859:0
2,556 sharesCommon StockSEC:0000899243-21-018274:0
13 of 13 declarations
